Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability.
about
Hypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritisPleiotropic effects of statinsStatins stimulate arachidonic acid release and prostaglandin I2 production in rat liver cellsHMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotectionDebate: Should statin be used in patients with heart failure?No effects on myocardial ischaemia in patients with stable ischaemic heart disease after treatment with ramipril for 6 monthsSimvastatin enhances bone marrow stromal cell differentiation into endothelial cells via notch signaling pathway.Protective effects of methotrexate against ischemic cardiovascular disorders in patients treated for rheumatoid arthritis or psoriasis: novel therapeutic insights coming from a meta-analysis of the literature data.The effects of high glucose and atorvastatin on endothelial cell matrix production.Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications.Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.Statins and cardiovascular diseases: from cholesterol lowering to pleiotropyAcute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx.Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interactionThe effect of statins on mortality in patients with bacteremia.Pre and Post-stroke Use of Statins Improves Stroke Outcome.Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients.Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease.Why might statins prevent venous thromboembolism: what needs to be done to know more?Thermography of the cardiovascular system.Effect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: a prospective cohort studyAtorvastatin inhibits inflammatory hypernociception.Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina: results from the Lescol intervention prevention study (LIPS).The Effects of Atorvastatin on Arterial Stiffness in Male Patients with Type 2 DiabetesStatin pre-treatment is associated with lower platelet activity and favorable outcome in patients with acute non-cardio-embolic ischemic strokeRosuvastatin and atorvastatin: comparative effects on glucose metabolism in non-diabetic patients with dyslipidaemia.Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.Cardiac allograft vasculopathy: a reviewDifferential metabolic actions of specific statins: clinical and therapeutic considerationsThe role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation.Low-density lipoprotein-lowering medication and platelet function.A low-dose atorvastatin and losartan combination directly improves aortic ring relaxation and diminishes ischaemic-reperfusion injury in isolated rat heartsA pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction.Rosuvastatin does not affect fasting glucose, insulin resistance, or adiponectin in patients with mild to moderate hypertensionVascular and metabolic effects of treatment of combined hyperlipidemia: focus on statins and fibrates.Are statins effective for simultaneously treating dyslipidemias and hypertension?Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia.Leptin and cardiovascular disease: response to therapeutic interventionsEvaluation of adverse effects of lisinopril and rosuvastatin on hematological and biochemical analytes in wistar rats.Flexible initial dosing of atorvastatin based upon initial low-density lipoprotein cholesterol levels in type 2 diabetic patients
P2860
Q24242787-1373D79B-0910-4DE9-A00E-C34AB8257191Q24647863-425BD591-4BC3-4091-9F4D-0ABDA5C8E0ECQ24792914-B33D85EA-026C-4F52-9F54-0A6492C848CFQ24793685-0A33B1AF-CC6D-418F-916C-0EF2BB4BB976Q24799305-D3002506-AD15-4BAB-BEEE-BAA5438FBBC7Q24804387-16ECFC86-7217-449C-AFFD-4CE329688751Q28581831-7FD16EAE-FB45-409F-92FF-56DA68392542Q31005025-3ECF4299-C3A7-476C-9517-0BB6B4F2B505Q31114710-6883D52F-DF4B-4BCC-A43A-F60213DB102FQ33585657-D7E31FCC-7C5D-40EC-BB35-81E3874206D2Q33821236-757F67F3-0325-4CAA-85B2-2C1D0FE7D773Q33960556-336E78C2-8C33-45E0-8629-0E23FB645440Q34116819-348A15F5-436F-4F11-880E-DE87450ACE6CQ34231611-29F6ADDE-3D04-4300-BD2A-E3C92898F393Q34374856-4EC736AC-0C96-4140-850A-54F974395E1AQ34432438-1F705775-60FD-4D69-B517-E98D88935845Q34467145-87197663-EF9C-4E5D-86F1-39893CD70019Q34618889-3D84E6E6-277A-4507-9BAE-F7257ECDA9BAQ35001052-2DC65128-3BC6-4365-B1B6-E9B4A549D950Q35022884-8AE5B2C7-8539-41D5-95DE-BA1728298D45Q35077842-DBF1BC32-53FA-489E-9B3F-17E5DF02134CQ35119935-4565F2B2-6D4B-4184-B4D7-86E28FBCFCBDQ35582952-1543B5D2-0CDE-41B2-8186-654B969EA87FQ35603481-35BF2489-C75E-47F8-ADEE-44D2CF8E42EBQ36070378-8226DE0C-D322-40B9-8926-0141A099C983Q36139098-87A74AE7-0F74-4421-8D90-D50BD3615CCFQ36242351-629EC7E4-E222-406C-A757-D4C6A692C3BAQ36252106-088BC68F-A736-4716-A491-D9511386E42AQ36406951-0CE3ED91-E1A8-4C05-BA1F-E5666B17B2BDQ36536154-9F900249-9C09-47BD-BBCE-399B11700E91Q36551327-6C1C3F1A-D904-4C34-870E-24DE33F8BD9FQ36577081-9B60B811-DF06-4F17-8708-F306830FF608Q36697677-4EC63997-D15E-4D6F-A335-14F939C683E9Q36837587-B6F140DE-AC4E-4108-9702-9C3EDF47A697Q36894180-BCE6EB65-0AC1-4D98-9D5A-01D0A96052EAQ36896062-34563FF8-80D2-4B13-9A47-DA7531BD9517Q37193394-D9A1744B-1B1C-4EB8-9213-B2FF52339B10Q37198354-E8861326-A0BF-459D-90B8-B610ECF9FB43Q37198943-B65E0849-9C62-4156-A247-00431ECF9519Q37203549-EF13DDBE-DD15-410C-AB2A-3A9B7A58845A
P2860
Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Effects of statins on vascular ...... mmation, and plaque stability.
@ast
Effects of statins on vascular ...... mmation, and plaque stability.
@en
Effects of statins on vascular ...... mmation, and plaque stability.
@nl
type
label
Effects of statins on vascular ...... mmation, and plaque stability.
@ast
Effects of statins on vascular ...... mmation, and plaque stability.
@en
Effects of statins on vascular ...... mmation, and plaque stability.
@nl
prefLabel
Effects of statins on vascular ...... mmation, and plaque stability.
@ast
Effects of statins on vascular ...... mmation, and plaque stability.
@en
Effects of statins on vascular ...... mmation, and plaque stability.
@nl
P1476
Effects of statins on vascular ...... mmation, and plaque stability.
@en
P2093
P304
P356
10.1016/S0008-6363(00)00146-2
P577
2000-09-01T00:00:00Z